Sondex PLC
31 August 2007
Sondex PLC
("Sondex" or the "Company")
The Board of Sondex notes the movement in its share price and confirms that it
is in advanced discussions regarding a possible offer for the Company.
The Board would like to stress that there can be no certainty that these
discussions will proceed to an offer being made for the Company.
A further announcement will be made in due course as appropriate.
Contacts and enquiries:
Sondex 01252 862 200
Martin Perry (Chief Executive)
Chris Wilks (Finance Director)
Investec
James Grace 020 7597 5140
Patrick Robb
Alex Thomas
College Hill 020 7457 2020
Nick Elwes
Paddy Blewer
31 August 2007
Under the provisions of Rule 8.3 of the Takeover Code (the 'Code'), if any
person is, or becomes, 'interested' (directly or indirectly) in 1% or more of
any class of 'relevant securities' of Seattle, all 'dealings' in any 'relevant
securities' of that company including by means of an option in respect of, or a
derivative referenced to, any such 'relevant securities') must be publicly
disclosed by no later than 3.30 pm (London time) on the London business day
following the date of the relevant transaction. This requirement will continue
until the date on which an offer for Sondex becomes, or is declared,
unconditional as to acceptances, lapses or is otherwise withdrawn or on which
the 'offer period' otherwise ends. If two or more persons act together pursuant
to an agreement or understanding, whether formal or informal, to acquire an
'interest' in 'relevant securities' of Seattle, they will be deemed to be a
single person for the purpose of Rule 8.3 of the Code.
Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant
securities' of Sondex by the offeror or the offeree company, or by any of their
respective 'associates', must be disclosed by no later than 12.00 noon (London
time) on the London business day following the date of the relevant transaction.
A disclosure table, giving details of the companies in whose 'relevant
securities''dealings' should be disclosed, and the number of such securities in
issue, can be found on the website of The Panel on Takeovers and Mergers (the
'Panel'), www.thetakeoverpanel.org.uk.
'Interests in securities' arise, in summary, when a person has long economic
exposure, whether conditional or absolute, to changes in the price of
securities. In particular, a person will be treated as having an 'interest' by
virtue of the ownership or control of securities, or by virtue of any option in
respect of, or derivative referenced to, securities.
Terms in quotation marks are defined in the Code, which can also be found on the
Panel's website. If you are in any doubt as to whether or not you are required
to disclose a 'dealing' under Rule 8 of the Code, you should consult the Panel.
Pursuant to Rule 2.10 of the City Code, Sondex confirms that it has 57,108,853
ordinary shares of 10p each in issue and admitted to trading on the London Stock
Exchange (ISIN GB0033047100).
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.